• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用伊维菌素进行群体治疗后盘尾丝虫病患病率降低。

Reduced prevalence of onchocerciasis following mass treatment with ivermectin.

作者信息

Oyibo W A, Fagbenro-Beyioku A F

机构信息

Department of Medical Microbiology and Parasitology, College of Medicine, University of Lagos, Idi-Araba, Nigeria.

出版信息

East Afr Med J. 1997 May;74(5):326-30.

PMID:9337014
Abstract

The effect of four years of cummulative annual treatment with ivermectin just before the fifth round of dosing with the drug was studied in six endemic communities where pretreatment data had been collected in 1992. Significant reductions in prevalence of microfilaridermics (PMF), skin microfilarial density (MFD) and community microfilarial load (CMFL) was recorded. Remarkable reductions in PMF were recorded in Gbodongi (53.0%), Ndanako (80.1%) and others. In all the communities, the infection was reduced to a hypo endemic status except for Gbodongi. This was corroborated by the increase in amicrofilaridermics. CMFL was reduced in Gbodongi by 64.2%, Lata (53.1%) and the least in Bongi (11.0%). Reduction in clinical manifestations were variable.

摘要

在1992年已收集治疗前数据的六个流行社区中,研究了在第五轮使用伊维菌素给药前连续四年每年使用该药物进行累积治疗的效果。记录到微丝蚴血症患病率(PMF)、皮肤微丝蚴密度(MFD)和社区微丝蚴负荷(CMFL)显著降低。在博东吉(53.0%)、恩达纳科(80.1%)等地记录到PMF显著降低。在所有社区中,除博东吉外,感染均降至低度流行状态。无微丝蚴血症者的增加证实了这一点。博东吉的CMFL降低了64.2%,拉塔降低了53.1%,邦吉降低最少,为11.0%。临床表现的减少各不相同。

相似文献

1
Reduced prevalence of onchocerciasis following mass treatment with ivermectin.用伊维菌素进行群体治疗后盘尾丝虫病患病率降低。
East Afr Med J. 1997 May;74(5):326-30.
2
Effect of repeated community-based ivermectin treatment on the intensity of onchocerciasis in Nigeria.基于社区的伊维菌素重复治疗对尼日利亚盘尾丝虫病感染强度的影响。
Rural Remote Health. 2003 Jul-Sep;3(2):211. Epub 2003 Sep 6.
3
Impact of 3 years ivermectin treatment on onchocerciasis in Yanomami communities in the Brazilian Amazon.三年伊维菌素治疗对巴西亚马逊地区亚诺马米社区盘尾丝虫病的影响。
Acta Trop. 2009 Nov;112(2):125-30. doi: 10.1016/j.actatropica.2009.07.009. Epub 2009 Jul 15.
4
Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon.伊维菌素重复治疗对喀麦隆北部盘尾丝虫病发病率的影响。
Am J Trop Med Hyg. 1995 Jul;53(1):63-7.
5
Epidemiological evaluation of onchocerciasis along Ogun River System, southwest Nigeria.尼日利亚西南部奥贡河系盘尾丝虫病的流行病学评估。
J Vector Borne Dis. 2012 Jun;49(2):101-4.
6
Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.健康教育对社区参与伊维菌素分发前盘尾丝虫病快速评估的影响。
East Afr Med J. 1999 Jun;76(6):320-3.
7
Control of onchocerciasis in Nzerem-Ikpem, Nigeria: baseline prevalence and mass distribution of ivermectin.尼日利亚恩泽雷姆-伊克佩姆盘尾丝虫病的控制:伊维菌素的基线患病率和群体分发情况
Public Health. 2000 Sep;114(5):402-6.
8
After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.在喀麦隆和乌干达进行了十年的年度大剂量伊维菌素治疗后,盘尾丝虫病的传播仍在继续。
Trop Med Int Health. 2008 Sep;13(9):1196-203. doi: 10.1111/j.1365-3156.2008.02126.x. Epub 2008 Jul 8.
9
The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic.在中非共和国加米村,每年使用伊维菌素(美迪善)进行为期5年的治疗对盘尾丝虫病的流行率和发病率的影响。
Ann Trop Med Parasitol. 2002 Apr;96(3):297-307. doi: 10.1179/000349802125000736.
10
Endemicity of onchocerciasis in some local government areas of Niger state.尼日尔州部分地方政府辖区盘尾丝虫病的地方性流行情况。
Afr J Med Med Sci. 2004 Mar;33(1):31-4.

引用本文的文献

1
Onchocerciasis in the upper imo river basin, Nigeria: prevalence and comparative study of waist and shoulder snips from mesoendemic communities.尼日利亚伊莫河上游流域的盘尾丝虫病:中度流行社区腰部和肩部活检患病率及对比研究
Iran J Parasitol. 2010 Jun;5(2):33-41.